stockrowAbbVie Inc.
ABBV Healthcare Drug Manufacturers General
AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024.
- Revenue
- +10.3%
- EPS
- +2,270.0%
- Free cash flow
- +9.97%
- Total debt
- +17.7%
Quarter to September 2026, against a year earlier
Follow ABBV
Alert me
AbbVie Inc. (ABBV) Gross margin
AbbVie Inc.'s gross margin over the twelve months to 30 September 2026 was 73.7%, up 3.5 percentage points from fiscal 2025 (70.2%). Over the past ten years it has ranged from 62.4% (fiscal 2023) to 80.3% (fiscal 2015); the current reading is higher than 55% of that period. That is in line with the Drug Manufacturers General industry median of 73.0% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 70.2% | 0.25 |
| FY2024 | 70.0% | 7.57 |
| FY2023 | 62.4% | (7.58) |
| FY2022 | 70.0% | 1.04 |
| FY2021 | 69.0% | 2.55 |
| FY2020 | 66.4% | (11.23) |
| FY2019 | 77.6% | 1.20 |
| FY2018 | 76.4% | 1.40 |
| FY2017 | 75.0% | (2.21) |
| FY2016 | 77.3% | (3.06) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 75.4% | 0.64 |
| Jun 2026 | 74.7% | 2.86 |
| Mar 2026 | 71.9% | (0.73) |
| Dec 2025 | 72.6% | 6.23 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| LLY Eli Lilly and Company compare | 83.6% |
| AZN AstraZeneca PLC compare | 81.9% |
| GILD Gilead Sciences, Inc. compare | 79.9% |
| NVS Novartis AG compare | 74.9% |
| ABBV AbbVie Inc. | 73.7% |
| PFE Pfizer Inc. compare | 73.4% |
| MRK Merck & Co., Inc. compare | 71.8% |
| AMGN Amgen Inc. compare | 70.9% |
| JNJ Johnson & Johnson compare | 67.6% |
| Drug Manufacturers General industry median | 73.0% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on ABBV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement